US Patent Issued to JCR Pharmaceuticals on July 21 for "Aqueous pharmaceutical composition containing fusion protein of serum albumin and growth hormone" (Japanese Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,762, issued on July 21, was assigned to JCR Pharmaceuticals Co. Ltd. (Ashiya, Japan).

"Aqueous pharmaceutical composition containing fusion protein of serum albumin and growth hormone" was invented by Shinji Okabe (Kobe, Japan), Yuka Yamaguchi (Kobe, Japan) and Hidehito Yasukawa (Kobe, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "An aqueous pharmaceutical composition containing 10-100 mg/mL of a fusion protein of human serum albumin and human growth hormone, 10-150 mg/mL of sucrose, 0.15-10 mg/mL of a nonionic surfactant, 0.5-12 mg/mL of a preservative, and 1-30 mM of a buffer is, and the pH of the composition is 5.0-8.0."

The patent was fi...